Compare CREG & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | CREG | MBAI |
|---|---|---|
| Founded | N/A | 2004 |
| Country | China | Israel |
| Employees | N/A | 85 |
| Industry | Power Generation | |
| Sector | Utilities | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9M | 12.0M |
| IPO Year | 2019 | N/A |
| Metric | CREG | MBAI |
|---|---|---|
| Price | $0.39 | $1.79 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 38.7M | 148.9K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $262,509.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.16 | $1.29 |
| 52 Week High | $2.66 | $3.92 |
| Indicator | CREG | MBAI |
|---|---|---|
| Relative Strength Index (RSI) | 45.37 | 53.41 |
| Support Level | $0.18 | $1.35 |
| Resistance Level | $1.42 | $1.91 |
| Average True Range (ATR) | 0.21 | 0.18 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 21.11 | 54.56 |
Smart Powerr Corp is engaged in waste energy recycling and is a developer of energy efficiency solutions for various energy intensive industries in China. It uses Build-Operate-Transfer (BOT) model to provide energy saving and recovery facilities for multiple energy intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. It provides a clean-technology and energy-efficient solution aimed at reducing the air pollution and energy shortage problems in China. The company's operations are conducted in one industry segment. All of its assets are located in the PRC.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.